Stith, Sarah S.
Li, Xiaoxue
Diviant, Jegason P.
Brockelman, Franco C.
Keeling, Keenan S.
Hall, Branden
Vigil, Jacob M. https://orcid.org/0000-0002-8534-2215
Article History
Received: 1 March 2020
Accepted: 13 November 2020
First Online: 9 December 2020
Ethics approval and consent to participate
: This study was approved by the University of New Mexico Institutional Review Board. All participants consented to have their anonymized recorded data statistically analyzed through the Releaf App Privacy Policy, which must be accepted before any cannabis use sessions can be recorded.
: All participants consented for their anonymous data to be disseminated in aggregate form.
: JMV is the Director of the University of New Mexico Medical Cannabis Research Fund, while the other authors are affiliated researchers. FB, KK, and BH developed the Releaf App and own MoreBetter, Ltd. The Releaf App generates revenue through allowing dispensaries to list their specific product offerings in the app, but no compensation is generated for users or the app owners through individual session entries. Publication of this article has no direct effect on compensation for MoreBetter, Ltd., or any of the authors beyond any increase visibility generated by the publication itself. The authors’ declare that they have no competing interests.